-
ADRX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of ADRX shares has decreased $0.06 since the market last closed. This is a 0.45% drop.
-
Closed at $13.23.
The stock has since dropped $0.20 in after-hours trading.
Key terms
About ADRX
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
-
Market cap: $1.47B
A market capitalization between $300 million and $2 billion places ADRX in the small capitalization category.
Key terms
Smart score
Latest ADRX news
ADRX Financials
-
Total revenue: $3.45M (1Y), $746.00K (Q2)
Total Revenue decreased 99.67% since last year and decreased 65.14% since last quarter.
-
Net income: -$73.09M (1Y), -$25.76M (Q2)
Net Income decreased 217.0% since last year and decreased 13.64% since last quarter.
-
Earnings per share: -$0.68 (1Y), -$0.24 (Q2)
EPS decreased 180.51% since last year and decreased 13.67% since last quarter.
Key terms
ADRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADRX Competitors
-
How competitors are chosen
ADRX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.47B
A market capitalization between $300 million and $2 billion places ADRX in the small capitalization category.
